These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10512094)

  • 21. A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal.
    Price JS; Waller PC; Wood SM; MacKay AV
    Br J Clin Pharmacol; 1996 Dec; 42(6):757-63. PubMed ID: 8971432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Withdrawal syndrome after the use of serotonin reuptake inhibitors].
    Fagan M
    Tidsskr Nor Laegeforen; 2000 Mar; 120(8):913-4. PubMed ID: 10795494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse events after the abrupt discontinuation of paroxetine.
    Dominguez RA; Goodnick PJ
    Pharmacotherapy; 1995; 15(6):778-80. PubMed ID: 8602387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Case Report of Serotonin Syndrome in a Patient on Selective Serotonin Reuptake Inhibitor (SSRI) Monotherapy.
    Hudd TR; Blake CS; Rimola-Dejesus Y; Nguyen TT; Zaiken K
    J Pharm Pract; 2020 Apr; 33(2):206-212. PubMed ID: 31030620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination risperidone and SSRI-induced serotonin syndrome.
    Karki SD; Masood GR
    Ann Pharmacother; 2003 Mar; 37(3):388-91. PubMed ID: 12639169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH; Goa KL
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resolution of Brugada-pattern ECG after withdrawal of the selective serotonin reuptake inhibitor paroxetine.
    Sawhney V; Thomas G; Webster P; Schilling R
    Heart; 2010 Jul; 96(14):1165-6. PubMed ID: 20478856
    [No Abstract]   [Full Text] [Related]  

  • 28. Similar discontinuation symptoms for withdrawal from medium-dose paroxetine and venlafaxine after nine years in the same patient.
    Kotzalidis GD; de Pisa E; Patrizi B; Savoja V; Ruberto G; Girardi P
    J Psychopharmacol; 2008 Jul; 22(5):581-4. PubMed ID: 18208915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Post-operative nystagmus and anisocoria due to serotonin toxicity?
    Gokcinar D; Karabeyoglu I; Ucar H; Gogus N
    Acta Anaesthesiol Scand; 2009 May; 53(5):694-5. PubMed ID: 19419379
    [No Abstract]   [Full Text] [Related]  

  • 30. [Severe withdrawal symptoms with fever during paroxetine tapering off].
    Peeters FP; Zandbergen J
    Ned Tijdschr Geneeskd; 1999 Jul; 143(27):1429-31. PubMed ID: 10422558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hallucinations caused by paroxetine taken together with a levodopa-carbidopa preparation].
    Freijzer PL; Brenninkmeijer JH
    Ned Tijdschr Geneeskd; 2002 Mar; 146(12):574-5. PubMed ID: 11938583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonin syndrome caused by minimum doses of SSRIS in a patient with spinal cord injury.
    Satoh K; Takano S; Onogi T; Ohtsuki K; Kobayashi T
    Fukushima J Med Sci; 2006 Jun; 52(1):29-33. PubMed ID: 16995352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contrasting actions of acute or chronic paroxetine and fluvoxamine on morphine withdrawal-induced place conditioning.
    Rafieian-Kopaei M; Gray AM; Spencer PS; Sewell RD
    Eur J Pharmacol; 1995 Mar; 275(2):185-9. PubMed ID: 7796854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroleptic malignant syndrome following combination of sertraline and paroxetine: a case report.
    Uguz F; Sonmez EÖ
    Gen Hosp Psychiatry; 2013; 35(3):327.e7-327.e8. PubMed ID: 23312145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Palinopsia and paroxetine withdrawal.
    Terao T
    J Clin Psychiatry; 2002 Apr; 63(4):368. PubMed ID: 12000213
    [No Abstract]   [Full Text] [Related]  

  • 36. Dextromethorphan-induced delirium and possible methadone interaction.
    Lotrich FE; Rosen J; Pollock BG
    Am J Geriatr Pharmacother; 2005 Mar; 3(1):17-20. PubMed ID: 16089243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acute dystonia following paroxetine withdrawal].
    Cabo-López I; García-Bermejo P; González-Roiz C; Durán-Martínez P; García-Ruiz PJ
    Rev Neurol; 2008 Feb 16-29; 46(4):253-4. PubMed ID: 18327750
    [No Abstract]   [Full Text] [Related]  

  • 38. [Serotonin syndrome associated to the use of paroxetine. Case report].
    Cavallazzi LO; Grezesiuk AK
    Arq Neuropsiquiatr; 1999 Sep; 57(3B):886-9. PubMed ID: 10751931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. More cases of paroxetine withdrawal syndrome.
    Pacheco L; Malo P; Aragues E; Etxebeste M
    Br J Psychiatry; 1996 Sep; 169(3):384. PubMed ID: 8879736
    [No Abstract]   [Full Text] [Related]  

  • 40. [Severe withdrawal symptoms with fever upon stopping paroxetine].
    Vergouwen AC; Kuipers T
    Ned Tijdschr Geneeskd; 1999 Aug; 143(35):1794-5; author reply 1795-6. PubMed ID: 10494332
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.